Skip to content

A study on acupoint application of ginger and tangerine warm-stomach cream combined with tropisetron and dexamethasone in the prevention and treatment of Chemotherapy Induced Nausea and Vomiting

A study on acupoint application of ginger and tangerine warm-stomach cream combined with tophan and dexamethasone in the prevention and treatment of Chemotherapy Induced Nausea and Vomiting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017589
Enrollment
Unknown
Registered
2018-08-05
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Group 1:Phase I: ginger and tangerine warm-stomach cream tropisetronon
Phase II: blank
Group 2:Phase I: blank, Phase II: ginger and tangerine warm-stomach cream tropisetronon

Sponsors

The First College of Clinical Medicine, Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients with colorectal cancer who have definite pathological diagnosis and ready to receive chemotherapy with regimen mFOLFOX6 or FOLFIRI; 2) KPS score greater than or equal to 70; 3) aged between 18 and 80 years; 4) good compliance, willing to cooperate with observation and treatment, and sign informed consent; 5) there was no gastrointestinal reaction including nausea and vomiting 24 hours before chemotherapy.

Exclusion criteria

Exclusion criteria: 1) heart, lung, brain, liver and kidney hematopoietic system diseases; 2) there are uncontrollable infections or metabolic diseases; 3) gastrointestinal symptoms caused by non-chemotherapy factors such as intestinal obstruction; 4) characteristic population (severe mental illness or advanced disease during lactation of pregnant women); 5) known allergic to traditional Chinese medicine.

Design outcomes

Primary

MeasureTime frame
response rate of CINV;MAT scale;

Secondary

MeasureTime frame
QLQ-C30;

Countries

China

Contacts

Public ContactJiang Mei

The First College of Clinical Medicine, Guangzhou University of Chinese Medicine

jiangmei619611@163.com+86 13924237899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026